| Item Type | Name |
|
Concept
|
Acetylation
|
|
Concept
|
Antibodies, Bacterial
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Australia
|
|
Concept
|
Congenital Abnormalities
|
|
Concept
|
Aged
|
|
Concept
|
Alabama
|
|
Concept
|
Altruism
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Antimetabolites, Antineoplastic
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Chromosomes, Human, Pair 11
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Anti-Inflammatory Agents
|
|
Concept
|
Cell Differentiation
|
|
Concept
|
Cell Movement
|
|
Concept
|
Attitude to Death
|
|
Concept
|
Body Height
|
|
Concept
|
Bone Neoplasms
|
|
Concept
|
Birth Weight
|
|
Concept
|
Biopsy
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Central Nervous System
|
|
Concept
|
Chromosomes, Human, Pair 1
|
|
Concept
|
Cell Cycle
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Chicago
|
|
Concept
|
Cooperative Behavior
|
|
Concept
|
Dacarbazine
|
|
Concept
|
Diffusion of Innovation
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Decision Support Techniques
|
|
Concept
|
DNA Repair
|
|
Concept
|
Chromosomes, Human, Pair 17
|
|
Concept
|
Ferritins
|
|
Concept
|
DNA (Cytosine-5-)-Methyltransferases
|
|
Concept
|
Hematopoietic Stem Cells
|
|
Concept
|
Image Interpretation, Computer-Assisted
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Mitosis
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Middle Aged
|
|
Concept
|
Cholesterol, HDL
|
|
Concept
|
Orbital Neoplasms
|
|
Concept
|
Melphalan
|
|
Concept
|
Patient Acceptance of Health Care
|
|
Concept
|
Quinoxalines
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Health Knowledge, Attitudes, Practice
|
|
Concept
|
Histones
|
|
Concept
|
Humans
|
|
Concept
|
Tretinoin
|
|
Concept
|
United States
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Wernicke Encephalopathy
|
|
Concept
|
Thiamine
|
|
Concept
|
Biomarkers
|
|
Concept
|
Isotretinoin
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Nurse's Role
|
|
Concept
|
Osteonectin
|
|
Concept
|
Up-Regulation
|
|
Concept
|
Stem Cell Transplantation
|
|
Concept
|
Proto-Oncogene Proteins c-myc
|
|
Concept
|
Radioimmunotherapy
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Ecosystem
|
|
Concept
|
North America
|
|
Concept
|
Apoptosis
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Antineoplastic Agents, Alkylating
|
|
Concept
|
Limbic Encephalitis
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Multidrug Resistance-Associated Proteins
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Bone Marrow Neoplasms
|
|
Concept
|
Hepatitis A Antibodies
|
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
|
Concept
|
Response Elements
|
|
Concept
|
Parents
|
|
Concept
|
Interdisciplinary Communication
|
|
Concept
|
Mice
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Biomedical Research
|
|
Concept
|
Anti-Retroviral Agents
|
|
Concept
|
Norepinephrine Plasma Membrane Transport Proteins
|
|
Concept
|
Social Stigma
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Vincristine
|
|
Concept
|
Suspensions
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Down-Regulation
|
|
Concept
|
HIV Infections
|
|
Concept
|
Hypoxia-Inducible Factor 1
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Concept
|
Cell Hypoxia
|
|
Concept
|
Immunoglobulins, Intravenous
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Buthionine Sulfoximine
|
|
Concept
|
Neoadjuvant Therapy
|
|
Concept
|
CD4 Lymphocyte Count
|
|
Concept
|
Microsatellite Repeats
|
|
Concept
|
Anti-HIV Agents
|
|
Concept
|
Topotecan
|
|
Concept
|
MAP Kinase Signaling System
|
|
Concept
|
Transcriptome
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Cytochromes c
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Comparative Genomic Hybridization
|
|
Concept
|
Epigenomics
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Antibodies
|
|
Concept
|
Benzenesulfonates
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Camptothecin
|
|
Concept
|
Cell Nucleolus
|
|
Concept
|
Chromosome Aberrations
|
|
Concept
|
Communication
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Naphthyridines
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Serum Albumin, Bovine
|
|
Concept
|
Translocation, Genetic
|
|
Concept
|
Signal Transduction
|
|
Concept
|
HIV-1
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Cost of Illness
|
|
Concept
|
Fenretinide
|
|
Concept
|
Age of Onset
|
|
Concept
|
Computational Biology
|
|
Concept
|
Genomics
|
|
Concept
|
Databases, Nucleic Acid
|
|
Concept
|
Medication Adherence
|
|
Concept
|
Young Adult
|
|
Academic Article
|
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth.
|
|
Academic Article
|
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.
|
|
Academic Article
|
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.
|
|
Academic Article
|
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
|
|
Academic Article
|
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
|
|
Academic Article
|
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study.
|
|
Academic Article
|
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
|
|
Academic Article
|
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
|
|
Academic Article
|
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
|
|
Academic Article
|
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.
|
|
Academic Article
|
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
|
|
Academic Article
|
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.
|
|
Academic Article
|
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.
|
|
Academic Article
|
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
|
|
Academic Article
|
Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaboration.
|
|
Academic Article
|
TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.
|
|
Academic Article
|
Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
|
|
Academic Article
|
Advances in the treatment of neuroblastoma.
|
|
Academic Article
|
Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
|
|
Academic Article
|
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
|
|
Academic Article
|
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group.
|
|
Academic Article
|
New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.
|
|
Academic Article
|
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
|
|
Academic Article
|
Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.
|
|
Academic Article
|
Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.
|
|
Academic Article
|
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
|
|
Academic Article
|
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
|
|
Academic Article
|
Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
|
|
Academic Article
|
Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.
|
|
Academic Article
|
A Selfless Act.
|
|
Academic Article
|
Genetic discoveries and treatment advances in neuroblastoma.
|
|
Academic Article
|
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.
|
|
Academic Article
|
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
|
|
Academic Article
|
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
|
|
Academic Article
|
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database.
|
|
Academic Article
|
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
|
|
Academic Article
|
The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy.
|
|
Academic Article
|
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.
|
|
Academic Article
|
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
|
|
Academic Article
|
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
|
|
Academic Article
|
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
|
|
Academic Article
|
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
|
|
Academic Article
|
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.
|
|
Academic Article
|
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group.
|
|
Grant
|
Mechanisms of Pancreatic Cancer Inhibition by SPARC
|
|
Grant
|
VARIATIONS BETWEEN RURAL AND URBAN AIDS CARE
|
|
Grant
|
MOLECULAR MECHANISMS OF DIFFERENTIATION IN NEUROBLASTOMA
|
|
Grant
|
Mechanism of SPARC peptide FSEC inhibition of angiogenesis in neuroblastoma
|
|
Grant
|
PEDIATRIC ONCOLOGY GROUP
|
|
Academic Article
|
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
|
|
Academic Article
|
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
|
|
Academic Article
|
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
|
|
Academic Article
|
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
|
|
Academic Article
|
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
|
|
Academic Article
|
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
|
|
Academic Article
|
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
|
|
Academic Article
|
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
|
|
Academic Article
|
Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer.
|
|
Academic Article
|
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
|
|
Academic Article
|
Reply to K. Beiske et al.
|
|
Academic Article
|
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.
|
|
Academic Article
|
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
|
|
Academic Article
|
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology Group.
|
|
Academic Article
|
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
|
|
Academic Article
|
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
|
|
Academic Article
|
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research.
|
|
Academic Article
|
Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.
|
|
Academic Article
|
HIV stigma and viral load among African-American women receiving treatment for HIV.
|
|
Academic Article
|
Women in HIV trials: improving adherence and outcomes.
|
|
Academic Article
|
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
|
|
Academic Article
|
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
|
|
Academic Article
|
Two-drug HIV regimens: more data still needed.
|
|
Academic Article
|
Repeat pregnancies among HIV-infected women enrolled in clinical trial PACTG1022.
|
|
Academic Article
|
Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy.
|
|
Academic Article
|
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.
|
|
Academic Article
|
Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy.
|
|
Academic Article
|
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group.
|
|
Academic Article
|
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
|
|
Academic Article
|
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.
|
|
Academic Article
|
MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia.
|
|
Academic Article
|
A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-related Research.
|
|
Academic Article
|
The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for 131I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study.
|
|
Academic Article
|
Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study.
|
|
Concept
|
Rituximab
|
|
Concept
|
N-Myc Proto-Oncogene Protein
|
|
Academic Article
|
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
|
|
Academic Article
|
In Memoriam: Sharon B. Murphy, MD (1943-2023).
|
|
Academic Article
|
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey study.
|